sinc
middecemb
worldwid
outbreak
coronaviru
diseas
covid
caus
formerli
first
detect
wuhan
china
incub
period
day
mean
day
case
long
day
commonli
seen
characterist
fever
cough
abnorm
chest
comput
tomographi
ct
present
chines
chrysanthemum
bat
thought
origin
base
sequenc
homolog
pangolin
propos
intermedi
host
confirm
humantohuman
transmiss
occur
mainli
via
respiratori
droplet
direct
contact
asymptomat
transmiss
intrafamili
manag
spread
epidem
import
strategi
combat
pandem
prevent
even
happen
shortag
person
protect
equip
ppe
mitig
use
reserv
suppli
acquir
donat
product
increas
appendix
figur
wuhan
shown
figur
tabl
emerg
staf
arrang
need
within
half
hour
requir
supplement
oxygen
hyperoxemia
may
induc
respiratori
injuri
even
higher
mortal
indic
supplement
oxygen
pharmacolog
agent
summar
treatment
pool
case
sever
case
tabl
inhal
patient
receiv
arbidol
lopinavirritonavir
receiv
inhal
chen
et
al
report
confirm
patient
wuhan
receiv
antivir
treatment
includ
oseltamivir
ganciclovir
lopinavir
ritonavir
durat
antivir
treatment
day
zhou
et
al
propos
hydroxychloroquin
could
serv
better
therapeut
agent
chloroquin
due
reduc
toxic
fewer
side
effect
lower
cost
rel
safeti
pregnanc
yao
et
al
use
physiologicallybas
pharmacokinet
pbpk
model
found
hydroxychloroquin
potent
chloroquin
inhibit
vitro
recommend
hydroxychloroquin
sulfat
mg
twice
daili
day
follow
mg
twice
daili
day
treat
infect
efficaci
safeti
data
chloroquin
hydroxychloroquin
highqual
clinic
trial
urgent
need
retrospect
studi
found
lowtomoder
dose
glucocorticoid
therapi
effect
time
viral
clearanc
patient
glucocorticoid
recommend
mild
case
improv
rate
radiograph
recoveri
howev
singlecent
wuhan
share
earli
lowdos
shortterm
day
corticosteroid
associ
faster
improv
clinic
symptom
absorpt
focal
lung
lesion
sever
case
anoth
studi
analyz
critic
case
suggest
low
dose
short
durat
corticosteroid
methylprednisolon
mgkg
less
day
may
benefici
critic
ill
patient
vaccin
develop
develop
vaccin
acceler
prioriti
project
improv
sampl
collect
accuraci
nucleic
acid
detect
patient
posit
assess
chang
regularli
avoid
decubitu
skin
injuri
due
fact
cardiac
insuffici
lead
coagul
disord
sever
patient
report
increas
level
ddimer
low
molecular
weight
heparin
recommend
treat
patient
earli
phase
diseas
sarscov
similarli
identifi
receptor
enter
cell
use
angiotensin
convert
enzym
inhibitor
acei
may
benefit
bind
receptor
also
mean
discontinu
acei
patient
necessari
regard
angiotensin
receptor
blocker
arb
evid
arb
could
lead
increas
express
thu
worsen
diseas
effect
import
public
health
intervent
whochina
joint
mission
report
report
china
vigor
public
health
measur
prevent
ambiti
agil
aggress
diseas
contain
effort
histori
drastic
measur
taken
list
tabl
nation
strategi
recogn
new
potenti
lethal
viru
viru
need
isol
viral
genom
sequenc
test
kit
valid
releas
rapid
distribut
infect
individu
contact
need
track
isol
earlier
done
less
impact
person
profession
live
peopl
economi
less
resourc
need
peopl
infect
drastic
measur
includ
shut
citi
restrict
travel
need
widespread
healthcar
resourc
exhaust
economi
take
bigger
hit
adult
meet
follow
criteria
respiratori
distress
breath
min
ii
oxygen
satur
rest
iii
arteri
partial
pressur
oxygen
fraction
inspir
oxygen
l
mmhg
whose
chest
imag
show
obviou
lesion
progress
within
hour
child
meet
follow
criteria
tachypnea
independ
fever
cri
ii
oxygen
satur
finger
puls
oximet
taken
rest
iii
labor
breath
cyanosi
intermitt
apnea
iv
lethargi
convuls
v
difficulti
feed
sign
dehydr
vi
hrct
show
infiltr
lung
multipl
lobe
lesion
progress
short
time
pleural
effus
mild
respiratori
support
highflow
nasal
oxygen
noninvas
ventil
invas
mechan
ventil
patient
meet
follow
criteria
respiratori
failur
requir
mechan
ventil
ii
shock
iii
organ
failur
requir
icu
care
